, Volume 46, Issue 5, pp 641–650 | Cite as

Invasive Candida auris infections in Kuwait hospitals: epidemiology, antifungal treatment and outcome

  • Ziauddin KhanEmail author
  • Suhail Ahmad
  • Khalifa Benwan
  • Prashant Purohit
  • Inaam Al-Obaid
  • Ritu Bafna
  • Maha Emara
  • Eiman Mokaddas
  • Aneesa Ahmed Abdullah
  • Khaled Al-Obaid
  • Leena Joseph
Original Paper



Candida auris is a recently recognized yeast pathogen, which has attracted worldwide attention due to its multidrug-resistant nature and associated high mortality rates. Its persistence in hospital environment and propensity of nosocomial transmission underscores the need of continuous monitoring to prevent outbreaks. Since the first case of C. auris candidemia in May, 2014, we have identified 17 additional invasive cases, which are described here.


Identity of 17 isolates originating from proven or possible cases of invasive C. auris infection and identified as Candida haemulonii by Vitek 2 yeast identification system was confirmed by PCR-sequencing of rDNA. Information about risk factors, treatment and outcomes were retrospectively retrieved from case files. Antifungal susceptibility testing was performed by Etest.


Thirteen cases of candidemia and 4 cases of other invasive infections were detected in 6 hospitals across Kuwait. Major risk factors included adult patients with cancer, diabetes, gastrointestinal/liver diseases and extended (> 25 days) hospital stay. All isolates were resistant to fluconazole. Additionally, 5 and 4 isolates were also resistant to voriconazole and amphotericin B, respectively. Despite antifungal treatment, 9 of 15 patients died. Most patients (n = 12) were hospitalized in 2 hospitals that are in close proximity, whereas 5 other patients were from 3 hospitals that are situated > 10 km apart.


Occurrence of successive cases of invasive C. auris infections with resulting mortality in nine patients suggests persistence of this multidrug-resistant yeast in major hospitals in Kuwait. Early detection by continuous surveillance and enforcement of infection control measures are recommended.


Candida auris Invasive infections Epidemiology Antifungal susceptibility Kuwait 



Authors are thankful to Soumya Varghese, Sandhya Vayalil and Omar Musallam for excellent technical support.

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.


  1. 1.
    Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 2017;13:e1006290.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Khan Z, Ahmad S. Candida auris: an emerging multidrug-resistant pathogen of global significance. Curr Med Res Pract. 2017;7:240–8.CrossRefGoogle Scholar
  3. 3.
    Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013;19:1670–3.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Emara M, Ahmad S, Khan Z, Joseph L, Al-Obaid I, Purohit P, et al. Candida auris candidemia in Kuwait, 2014. Emerg Infect Dis. 2015;21:1091–2.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S, et al. Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg Infect Dis. 2017;23:195–203.CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Al-Siyabi T, Al-Busaidi I, Balkhair A, Al-Muharrmi Z, Al-Salti M, Al’Adawi B. First report of Candida auris in Oman: clinical and microbiological description of five candidemia cases. J Infect. 2017;75:373–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Mohsin J, Hagen F, Al-Balushi ZAM, de Hoog GS, Chowdhary A, Meis JF, Al-Hatmi A. The first cases of Candida auris candidaemia in Oman. Mycoses. 2017;60:569–75.CrossRefPubMedGoogle Scholar
  9. 9.
    Alatoom A, Sartawi M, Lawlor K, Abdel-Wareth L, Thomsen J, Nusair A, Mirza I. Persistent candidemia despite appropriate fungal therapy: first case of Candida auris from the United Arab Emirates. Int J Infect Dis. 2018;70:36–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Khan ZU, Ahmad S, Al-Sweih N, Joseph L, Alfouzan F, Asadzadeh M. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. PLoS One. 2018;13:e0195743.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Khan ZU, Ahmad S, Mokaddas E, Chandy R, Cano J, Guarro J. Actinomucor elegans var. kuwaitiensis isolated from the wound of a diabetic patient. Antonie van Leeuwoenhoek. 2008;94:343–52.CrossRefGoogle Scholar
  12. 12.
    Khan ZU, Ahmad S, Hagen F, Fell JW, Kowshik T, Chandy R, et al. Cryptococcus randhawai sp. nov., a novel anamorphic basidiomycetous yeast isolated from tree trunk hollow of Ficus religiosa (peepal tree) from New Delhi, India. Antonie Van Leeuwenhoek. 2010;97:253–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Asadzadeh M, Al-Sweih NA, Ahmad S, Khan ZU. Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait. Mycoses. 2008;51:318–23.CrossRefPubMedGoogle Scholar
  14. 14.
    Arendrup MC, Prakash A, Meletiadis J, Sharma C, Chowdhary A. Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values. Antimicrob Agents Chemother. 2017;61:pii: e00485-17.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Centers for Disease Control and prevention (CDC). Recommendations for identification of Candida auris. 2017. Accessed 30 Oct 2017
  16. 16.
    Lockhart SR, Berkow EL, Chow N, Welsh RM. Candida auris for the clinical microbiology laboratory: Not your grandfather’s Candida species. Clin Microbiol Newsl. 2017;39:99–103.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Kohlenberg A, Struelens MJ, Monnet DL, Plachouras D, The Candida auris Survey Collaborative Group. Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017. Euro Surveill. 2018;23.Google Scholar
  18. 18.
    Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med. 2015;41:285–95.CrossRefPubMedGoogle Scholar
  19. 19.
    Rudramurthy SM, Chakrabarti A, Paul RA, Sood P, Kaur H, Capoor MR, et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother. 2017;72:1794–801.CrossRefPubMedGoogle Scholar
  20. 20.
    Mathur P, Hasan F, Singh PK, Malhotra R, Walia K, Chowdhary A. Five-year profile of candidemia at an Indian Trauma Center: high rates of Candida auris blood stream infections. Mycoses. 2018. Scholar
  21. 21.
    Calvo B, Melo ASAA., Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016;73:369–74.CrossRefPubMedGoogle Scholar
  22. 22.
    Morales-López SE, Parra-Giraldo CM, Ceballos-Garzón A, Martínez HP, Rodríguez GJ, Álvarez-Moreno CA, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis. 2017;23:162–4.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Ruiz-Gaitan A, Moret AM, Tasias-Pitarch M, Aleixandre-Lopez AI, Martínez-Morel H, Calabuig E, Salavert-Lletí M, Ramírez P, López-Hontangas JL, Hagen F, Meis JF, Mollar-Maseres J, Pemán J. An outbreak due to Candida auris with prolonged colonization and candidemia in a tertiary care European hospital. Mycoses. 2018. Scholar
  24. 24.
    Araúz AB, Caceres DH, Santiago E, Armstrong P, Arosemena S, Ramos C, et al. Isolation of Candida auris from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing. Mycoses. 2018;61:44–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CL. J Clin Microbiol. 2015;53:1823–30.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64:134–40.CrossRefPubMedGoogle Scholar
  27. 27.
    Magobo RE, Corcoran C, Seetharam S, Govender NP. Candida auris-associated candidemia, South Africa. Emerg Infect Dis. 2014;20:1250–1.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus—United States, May 2013–August 2016. MMWR Morb Mortal Wkly Rep. 2016;65:1234–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Prakash A, Sharma C, Singh A, Kumar Singh P, Kumar A, Hagen F, et al. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. Clin Microbiol Infect. 2016;22:277.e1–277.e9.CrossRefGoogle Scholar
  30. 30.
    Sarma S, Kumar N, Sharma S, Govil D, Ali T, Mehta Y, et al. Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol. 2013;31:90–1.CrossRefPubMedGoogle Scholar
  31. 31.
    Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53:41–4.CrossRefGoogle Scholar
  32. 32.
    Kim MN. Shin JH, Sung H, Lee K, Kim EC, Ryoo N, et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: Identification, antifungal susceptibility, and clinical features. Clin Infect Dis. 2009;48:e57–e61.CrossRefPubMedGoogle Scholar
  33. 33.
    Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, Jang HC. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49:3139–42.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Chowdhary A, Anil Kumar V, Sharma C, Prakash A, Agarwal K, Babu R, et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis. 2014;33:919–26.CrossRefPubMedGoogle Scholar
  35. 35.
    Khillan V, Rathore N, Kathuria S, Chowdhary A. A rare case of breakthrough fungal pericarditis due to fluconazole-resistant Candida auris in a patient with chronic liver disease. JMM Case Rep. 2014;1:1–5.CrossRefGoogle Scholar
  36. 36.
    Okinda N, Kagotho E, Castanheira M, Njuguna A, Omuse G, Makau P, et al. Candidemia at a referral hospital in sub-Saharan Africa: emergence of Candida auris as a major pathogen. In: European conference on clinical microbiology and infectious: Barcelona; May 10–13 2014.Google Scholar
  37. 37.
    Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, et al. The Emerging Candida auris: characterization of growth phenotype, virulence factors, antifungal activity, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother. 2017; 61:AAC.02396-16.CrossRefGoogle Scholar
  38. 38.
    Choi HI, An J, Hwang JJ, Moon SY, Son JS. Otomastoiditis caused by Candida auris: Case report and literature review. Mycoses. 2017;60:488–92.CrossRefPubMedGoogle Scholar
  39. 39.
    Schwartz IS, Hammond GW. First reported case of multidrug-resistant Canada auris. Can Commun Dis Rep. 2017;43:150–3.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Tap RM, Lim TC, Kamarudin NA, Ginsapu SJ, Abd Razak MF, Ahmad N, et al. A fatal case of Candida auris and Candida tropical candidemia in neutropenic patient. Mycopathologia. 2018. (Epub ahead of print).CrossRefGoogle Scholar
  41. 41.
    Belkin A, Gazit Z, Keller N, Ben-Ami R, Wieder-Finesod A, Novikov A, et al. Candida auris infection leading to nosocomial transmission, Israel, 2017. Emerg Infect Dis. 2018;24:801–4.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55:2996–3005.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Chowdhary A, Voss A, Meis JF. Multidrug-resistant Candida auris: ‘new kid on the block’ in hospital-associated infections? J Hosp Infect. 2016;94:209–12.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Ziauddin Khan
    • 1
    • 5
    Email author
  • Suhail Ahmad
    • 1
    • 5
  • Khalifa Benwan
    • 2
  • Prashant Purohit
    • 3
  • Inaam Al-Obaid
    • 3
  • Ritu Bafna
    • 3
  • Maha Emara
    • 3
  • Eiman Mokaddas
    • 1
    • 4
  • Aneesa Ahmed Abdullah
    • 4
  • Khaled Al-Obaid
    • 5
  • Leena Joseph
    • 1
  1. 1.Department of Microbiology, Faculty of MedicineKuwait UniversityKuwait CityKuwait
  2. 2.Department of MicrobiologyAl-Amiri HospitalKuwait CityKuwait
  3. 3.Department of MicrobiologyAl-Sabah HospitalKuwait CityKuwait
  4. 4.Department of MicrobiologyIbn-Sina HospitalKuwait CityKuwait
  5. 5.Department of MicrobiologyMubarak Al-Kabeer HospitalJabriyaKuwait

Personalised recommendations